TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Sana Pharma Medical AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
5,676
|
5,037
|
5,862 |
| Financial expenses |
269
|
126
|
99 |
| Earnings before taxes |
-831
|
-931
|
-63 |
| Total assets |
6,810
|
5,853
|
4,472 |
| Current assets |
5,356
|
4,174
|
2,750 |
| Current liabilities |
7,309
|
5,145
|
3,106 |
| Equity capital |
-500
|
349
|
1,367 |
| - share capital |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
-7.3%
|
6.0%
|
30.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-14.6%
|
-18.5%
|
-1.1% |
| Return on assets (ROA) |
-8.3%
|
-13.8%
|
0.8% |
| Current ratio |
73.3%
|
81.1%
|
88.5% |
| Return on equity (ROE) |
166.2%
|
-266.8%
|
-4.6% |
| Change turnover |
896
|
-452
|
-174 |
| Change turnover % |
19%
|
-8%
|
-3% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.